Harpoon Therapeutics competitors and similar companiesClear all

Harpoon Therapeutics's competitors and similar companies include Xione Therapeutics, Olema Oncology, Pangaea Oncology and Coherus BioSciences.
Harpoon Therapeutics
Harpoon Therapeutics
Harpoon Therapeutics is a preclinical stage biotechnology company.
Xione Therapeutics
Xione Therapeutics
Xione Therapeutics is a biotechnology company that operates in the anti-tumor immunity segment.
Olema Oncology
Olema Oncology
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
Pangaea Oncology
Pangaea Oncology
Pangaea Oncology is a company providing research and development services in the field of personalized cancer treatment.
Coherus BioSciences
Coherus BioSciences
Coherus BioSciences is a biopharmaceutical company that focuses on the biosimilar and immuno-oncology market.
Founding Date
Founding Date
2015
Founding Date
2019
Founding Date
2007
Founding Date
2007
Founding Date
2010
Type
Type
Public
Type
Private
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Louisville, US
South San Francisco, US
Locations
Houston, US HQ
Locations
San Francisco, US HQ
San Francisco, US
Locations
Barcelona, ES HQ
Locations
Redwood City, US HQ
Camarillo, US
Employees
Employees
45
Employees
1
Employees
21
Employees
244% decrease
Employees
3102% decrease
Valuation ($)
Valuation ($)
33.4 m
Valuation ($)
N/A
Valuation ($)
184.1 m
Valuation ($)
N/A
Valuation ($)
653.3 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
218
Twitter followers
302
Twitter followers
3.7 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
3
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
0.7
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
54.55%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
66.67%
Alexa Website Rank
Alexa Website Rank
255858
Alexa Website Rank
N/A
Alexa Website Rank
506603
Alexa Website Rank
N/A
Alexa Website Rank
371917
Employee Rating
Employee Rating
4.3
Employee Rating
N/A
Employee Rating
4.7
Employee Rating
N/A
Employee Rating
4

Financial

Revenue (est.)
Revenue (est.)
$23.7m (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$326.6m (FY, 2021)
Net income
Net income
($116.7m) (FY, 2021)
Net income
N/A
Net income
($71.1m) (FY, 2021)
Net income
N/A
Net income
($287.1m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 130m
Total funding raised
N/A
Total funding raised
$ 145.1m
Total funding raised
N/A
Total funding raised
$ 174.5m
For sources of this data, please see the company profile

View company profiles

Xione Therapeutics
HQ
Houston, US
Employees
1

Xione Therapeutics is a biotechnology company that operates in the anti-tumor immunity segment.

View company
Olema Oncology
HQ
San Francisco, US
Employees
21

Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.

View company
Pangaea Oncology
HQ
Barcelona, ES
Employees
24↓ 4% decrease

Pangaea Oncology is a company providing research and development services in the field of personalized cancer treatment.

View company
Coherus BioSciences
HQ
Redwood City, US
Employees
310↓ 2% decrease

Coherus BioSciences is a biopharmaceutical company that focuses on the biosimilar and immuno-oncology market.

View company